Cell Metabolism, 27 (4), 740756
Lawitz EJ, Coste A, Poordad F et al (2018) Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis
Congressional Record Discussion on TRICARE Coverage of Obesity Treatments Provides background on the legislative framework that guides TRICAREs coverage limitations for weight-loss medications
His approach combines a self-nomination by potential lead counsels and subsequent approval through a consensus among fellow plaintiffs attorneys, a process that could influence future complex litigations
For Grns, that was the product itself
Gastrointestinal side effectssuch as nausea, vomiting, diarrhea, and constipationwere the most commonly reported, consistent with the GLP-1 drug class